Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

Healthcare Biotechnology

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc > Chef

<< Previous

Bullboard Posts

Next >>

Comment by Chefboy69on May 05, 2024 3:51pm

73 Views

Post# 36024034

RE:Chef

1991nightmaress wrote: The only thing you add is constant ridicule and belittling to the the stock and the chat sites .... the only one here wasting his and everyone else's time is you

And I see you haven't brought anything to the table. the CSE and TSX venture volumes tell you everything you need to know. Nobody listens to people on Twitter followers anymore this is 2024.. what you have to understand is your whole way of making money is now done.
No more retail bag holders to steal from.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features